T. Rowe Price Associates »

Syndax Pharmaceuticals shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $568k 26k 21.62
2023-09-30 $355k 24k 14.54
2023-06-30 $481k 23k 20.97
2023-03-31 $241k 11k 21.21
2022-12-31 $238k 9.4k 25.42
2021-09-30 $9.9M 516k 19.11
2021-06-30 $7.2M 420k 17.17
2021-03-31 $9.8M 439k 22.36
2020-12-31 $3.8M 171k 22.24